Otezla®: A Post-Topical Option for Psoriasis

Sponsored by Amgen Australia Pty Ltd

In February, Amgen invited Australian dermatologists to the launch of Otezla (apremilast) for patients with chronic plaque psoriasis now listed on the Pharmaceutical Benefits Scheme.1,2 International guest speaker Dr Linda Stein Gold, Director of Dermatology Clinical Research at Henry Ford Health System in Detroit, Michigan was joined by local faculty members Dr Diana Rubel and ...

Already a member?

Login to keep reading.

© 2021 the limbic